Predominance of CD8+ T lymphocytes in psoriatic arthritis

Journal of Rheumatology

Volumn 26, Issue 5, 1999, Pages 1117-1124

  Costello, Patrick ^a,b   Bresnihan, Barry ^a,c   O'Farrelly, Cliona ^a,b   Fitzgerald, Oliver ^a,c  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b Education and Research Centre

^c Department of Rheumatology ^*  (Ireland)

Author keywords

CD8+ T cells; MHC class I; Psoriatic arthritis; T lymphocyte

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 1; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0032953514     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Winchester R. Psoriatic arthritis. Dermatol Clin 1995;13:779-92.
2. FitzGerald O, Kane D. Clinical, immunopathogenic, and therapeutic aspects of psoriatic arthritis. Curr Opin Rheumatol 1997;9:295-301.
3. Panayi G. Immunology of psoriasis and psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:419-27.
4. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, FitzGerald O. Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993; 36:893-900.
5. Winchester R. Psoriatic arthritis. In: Freedberg F, Austin K, editors. Dermatology in general medicine. 4th ed. New York, NY: McGraw-Hill; 1993:515-27.
6. Espinoza LR, Jara LJ, Espinoza CG, Silveira LH, Martinez-Osuna P, Seleznick M. There is an association between human immunodeficiency virus infection and spondyloarthropathies. Rheum Dis Clin North Am 1992;18:257-66.
7. Winchester RJ. HIV infection and rheumatic disease. Bull Rheum Dis 1994;43:5-8.
8. Rowe IF. Arthritis in the acquired immunodeficiency syndrome and other viral infections. Curr Opin Rheumatol 1991;3:621-7.
9. Hardman CM, Baker BS, Lortan J, et al. Active psoriasis and profound CD4+ lymphocytopenia. Br J Dermatol 1997;136:930-2.
10. Paukkonen K, Naukkarinen A, Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8+ T-cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 1992;284:375-9.
11. Gottlieb SL, Gilleaudeau P, Johnson R, et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995;1:442-7.
12. Chang JC, Smith LR, Froning KJ, et al. CD8+ T-cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13:1 genes. Proc Natl Acad Sci USA 1994;91:9282-6.
13. Kingsley G, Pitzalis C, Kyriazis N, Panayi GS. Abnormal helper-inducer/suppressor-inducer T-cell subset distribution and T-cell activation status are common to all types of chronic synovitis. Scand J Immunol 1988;28:225-32.
14. Morimoto C, Romain PL, Fox DA, et al. Abnormalities in CD4+ T-lymphocyte subsets in inflammatory rheumatic diseases. Am J Med 1988;8:817-25.
15. Crockard AD, Finch MB, Fay AC, McNeill TA, Bell AL, Roberts SD. Comparative analysis of CD4 subsets in peripheral blood and synovial fluid of patients with inflammatory joint disease. Scand J Rheumatol 1990;19:157-61.
16. Nilsson E, Biberfeld G. T lymphocyte subpopulations defined by monoclonal antibodies in synovial fluid of patients with rheumatic disease. J Clin Lab Immunol 1982;9:93-97.
17. Nilsson E, Biberfeld G. Differences in the distribution of synovial T lymphocyte subpopulations between patients with acute and chronic exudative synovitis. Clin Exp Rheumatol 1984;2:57-62.
18. Cantagrel A, Roubinet F, Lassoued S, et al. The transsynovial lymphocytic ratio: characterization of blood and synovial fluid lymphocytes from patients with arthritic diseases. J Rheumatol 1988;15:899-904.
19. Veale D, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133-8.
20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987;31:315-24.
21. Bacon P. Extra-articular rheumatoid arthritis. In: McCarthy DJ, Koopman W, editors. Arthritis and allied conditions. 12th ed. Philadelphia: Lea & Febiger; 1993.
22. Smith MD, Roberts-Thomson PJ. Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo. Ann Rheum Dis 1990;49:81-7.
23. Chen C, Huang S, Chen C, Yen M, Hsu H, Ho H. Increased expression of CD69 and HLA-DR but not of CD25 or CD71 on endometrial T lymphocytes of nonpregnant women. Hum Immunol 1995;42:227-32.
24. Iannone F, Corrigall VM, Kingsley GH, Panayi GS. Evidence for the continuous recruitment and activation of T-cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994;24:2706-13.
25. Tada Y, Ho A, Koh DR, Mak TW. Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T-cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol 1996;156:4520-6.
26. Halverson DC, Schwartz GN, Carter C, Gress RE, Fowler DH. In vitro generation of allospecific human CD8+ T-cells of Tc1 and Tc2 phenotype. Blood 1997;90:2089-96.
27. Ritchlin C, Haas-Smith S, Cappuccio J, Varnis C, Osterland K, Looney RJ. Cytokine production by psoriatic skin and synovium [abstract]. Arthritis Rheum 1994;37 Suppl 9:S205.
28. Jinquan T, Larsen CG, Gesser B, Matsushima K, Thestrup-Pedersen K. Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8 induced CD4+ T lymphocyte migration. J Immunol 1993;151:4545-51.
29. Chang JC, Smith LR, Froning KJ, et al. Persistence of T-cell clones in psoriatic lesions. Arch Dermatol 1997;133:703-8.
30. Wrone-Smith T, Nickoloff B. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996;98:1878-87.
31. Bachelez H, Flageul B, Dubertret L, et al. Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4. J Autoimmun 1998;11:53-62.
32. Schon M, Detmar M, Parker C. Murine psoriasis-like disorder induced by naive CD4+ T-cells. Nat Med 1997;3:183-8.
33. Breban M, Luis Fernandez-Sueiro J, Richardson J, et al. T-cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996;156:794-803.
34. Baker BS, Swain AF, Fry L, Valdimarsson H. Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 1984;100:555-64.